BLOG

According to Marqeta survey 49% of participants finds payment implants useful and safe. As digital payments become more common, the variety of ways we can pay for goods and services electronically is evolving and multiplying. How will this change over the next 10 years? Cryptocurrency, biometrics, implants and machine-controlled payments have been discussed at length in the media.
Continue reading

What do you think when you hear the word "cyborg"? Can you imagine a man connected to the latest technology supporting essential life functions? Maybe you think about scenes from the movie "Terminator" in which Arnold Schwarzenegger played the role of a cyborg. Apart from such cases, multiple solutions allow tech-enthusiasts to experience the latest trends, literally, inside-out. 

Continue reading

The industry of modern financial technologies is gaining strength every year and its development is extremely dynamic. More and more new solutions are used every day and the range of available options is increasing. Today it is possible to make purchases without having your traditional wallet in the pocket of your jeans, smartphone or even a watch on your wrist, and this is just the beginning of the advantages offered by manufacturers of intelligent implants.

Continue reading

The biggest and the most prestigious fin-tech conference in the world, where the latest solutions and trends from the world of finance are presented and discussed. This time, one of the Money20/20 participants will be also Wojciech Paprota - founder and CEO of Walletmor. It will be very important and productive time for Walletmor, not only because of Wojciech Paprota's speech but also to establish and strengthen business contacts at the highest level.

Continue reading

Fintech start-up Walletmor has confirmed the safety of its payment implant with further scientific research. The latest tests carried out by Konmex BioLabs confirmed the implant does not exhibit cytotoxic properties and can be perminantly implanted e.g. in subdermal fascia tissue (under the skin). Tests were conducted in accordance with bio-compatibility standards ISO 10993-5:2009E (cytotoxicity) and 10993-12:2021E. Walletmor plans further testing and international certification of its implant.

Continue reading